Docosatetraenoic acid (DTA; cis-22:4n-6)

ID247
NameDocosatetraenoic acid (DTA; cis-22:4n-6)
Synonymsall-cis-7,10,13,16-Docosatetraenoic acid; Adrenic acid; 22:4n-6
StructureThumb
Description
GroupFatty acids
Sub-groupPUFA
Exposure sourceDiet
Use
CAS number28874-58-0
PubChem ID5497181
ChEBI ID53487
FooDB IDFDB022918
HMDB IDHMDB02226

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
197319792AllNear-term pregnant womenCanadaCARed blood cell membrane (Phosphatidylcholine), fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)1050.270.1percentRoot0.3 percentRootCrudeFriesen 2010
199019962AllNear-term pregnant womenCanadaCARed blood cell membrane (Ethanolamine phosphoglyceride), fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)1055.481.3percentRoot5.5 percentRootCrudeFriesen 2010
3021101571MalesMiddle-aged participants in a nested case-control studyFranceFRSU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants)Plasma, fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2760.210.07percentRoot0.2 percentRootCrudeAstorg 2008
3048101581FemalesMiddle-aged participants in a nested case-control studyFranceFRSU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants)Plasma, fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2570.20.07percentRoot0.2 percentRootCrudeAstorg 2008
452245233AllControls in a case-control study on diet and heart diseaseCosta RicaCRAdipose tissue, buttocksGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2000.210.07percentRoot0.2 percentRootCrudeBaylin 2005
456145623AllControls in a case-control study on diet and heart diseaseCosta RicaCRPlasma, fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2000.260.1percentRoot0.3 percentRootCrudeBaylin 2005
460046013AllControls in a case-control study on diet and heart diseaseCosta RicaCRWhole blood, fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2001.280.31percentRoot1.3 percentRootCrudeBaylin 2005
547654702AllControls in a case-control study on diet and heart diseaseCosta RicaCRAdipose tissue, buttocksGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)5030.220.07percentRoot0.2 percentRootCrudeBaylin 2002
564556462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)352.9530.7561.5814.406percentRoot3.0 percentRootCrudeParra 2002
633563473AllObese patients in a clinic from MurciaSpainESAdipose tissue, periumbilical (subcutaneous)GC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)760.240.31percentRoot0.2 percentRootCrudeGaraulet 2001
636063723AllObese patients in a clinic from MurciaSpainESAdipose tissue, intraabdominal (perivisceral)GC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)570.180.19percentRoot0.2 percentRootCrudeGaraulet 2001
638563973AllObese patients in a clinic from MurciaSpainESAdipose tissue, intraabdominal (omental)GC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)240.160.17percentRoot0.2 percentRootCrudeGaraulet 2001
801780252AllMiddle-aged women in the Trondheim areaNorwayNOParticipants in a cardiovascular screening by SHUS (National Health Screening Service)Serum, non-fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2340.230.07percentRoot0.2 percentRootCrudeHjartaker 1997
804480522AllMiddle-aged women in the Trondheim areaNorwayNOParticipants in a cardiovascular screening by SHUS (National Health Screening Service)Serum, non-fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)2342.871.04mg/L2.9 mg/LCrudeHjartaker 1997
867586802All [by gender]Obese subjects with non-insulin-dependent diabetes mellitusNetherlandsNLProspective study on weight lossbaseline; 1 year; 2 yearsAdipose tissue (triglycerides), abdomenGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)530.250.07percentRoot0.3 percentRootCrudePopp-Snijders 1995
869386982MalesObese subjects with non-insulin-dependent diabetes mellitusNetherlandsNLProspective study on weight lossbaseline; 1 year; 2 yearsAdipose tissue (triglycerides), abdomenGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)190.210.06percentRoot0.2 percentRootCrudePopp-Snijders 1995
871187162FemalesObese subjects with non-insulin-dependent diabetes mellitusNetherlandsNLProspective study on weight lossbaseline; 1 year; 2 yearsAdipose tissue (triglycerides), abdomenGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)340.280.07percentRoot0.3 percentRootCrudePopp-Snijders 1995
896290502MalesAdults living in CopenhagenDenmarkDKAdipose tissue, buttocksGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)230.00.0percentRoot0.0 percentRootCrudeTjonneland 1993
899290532FemalesAdults living in CopenhagenDenmarkDKAdipose tissue, buttocksGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)630.00.0percentRoot0.0 percentRootCrudeTjonneland 1993
1014693512AllControls in a study on diet and breast cancer in Boston areaUnited StatesUSAdipose tissue, buttocksGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)1150.220.080.090.59percentRoot0.2 percentRootCrudeLondon 1991
18608186093AllWomenUnited StatesUSNYUWHS (New York University Women's Health Study)baselinePlasma, non-fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)460.620.37percentRoot0.6 percentRootUnspecifiedZeleniuch-Jacquotte 2000

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
448344843AllControls in a case-control study on diet and heart diseaseCosta RicaCRFood Frequency Questionnaire (FFQ)Docosatetraenoic acid (DTA; cis-22:4n-6)2000.030.02percentRoot0.0 percentRootRegressionEnergy ?Baylin 2005

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
26518581AllWomenUnited StatesUSNYUWHS (New York University Women's Health Study)baseline; 1 year; 2 yearsPlasma, non-fastingGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)percentRoot460.630.490.77Zeleniuch-Jacquotte 2000